Symbol="CYCC"
AssetType="Common Stock"
Name="Cyclacel Pharmaceuticals Inc"
Description="Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer and other proliferative diseases. The company is headquartered in Berkeley Heights, New Jersey."
CIK="1130166"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="4728400"
EBITDA="-28529000"
PERatio="None"
PEGRatio="0"
BookValue="0.406"
DividendPerShare="0"
DividendYield="0"
EPS="-1.89"
RevenuePerShareTTM="0.03"
ProfitMargin="0"
OperatingMarginTTM="-76.57"
ReturnOnAssetsTTM="-0.689"
ReturnOnEquityTTM="-1.345"
RevenueTTM="373000"
GrossProfitTTM="-455000"
DilutedEPSTTM="-1.89"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="12.25"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="74.57"
PriceToBookRatio="0.336"
EVToRevenue="6.1"
EVToEBITDA="0.58"
Beta="1.078"
num_52WeekHigh="1.77"
num_52WeekLow="0.34"
num_50DayMovingAverage="0.59"
num_200DayMovingAverage="0.717"
SharesOutstanding="12642800"
DividendDate="2020-04-15"
ExDividendDate="None"
symbol="CYCC"
open="0.45"
high="0.46"
low="0.34"
price="0.37"
volume="412673.00"
latest_trading_day="2023-08-25"
previous_close="0.45"
change="-0.08"
change_percent="-16.8889%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="61"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="39"
Volume_recent_avg="74010"
Change_recent_avg="-0.01"
Delta_recent_avg="0.06"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-1.66"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_10"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="39"
Aroon_momentum_negative="61"
image_negative_thumbnail_id_1="487"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0118.jpeg"
image_negative_thumbnail_id_2="508"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0097.jpeg"
image_neutral_thumbnail_id_1="573"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_neutral_thumbnail_id_2="559"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0040.jpeg"
image_positive_thumbnail_id_1="1012"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0174.jpeg"
image_positive_thumbnail_id_2="1004"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0166.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1175"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
